Genomic & Biopharma NewsSix new medicines endorsed for EU approval
Six new medicines, including the first hormone replacement therapy for a thyroid disorder, have been put forward for approval by the European Medicines Agency's Committee for Medicinal Products for Human Use.
|PharmaTimes, 2017-02-27 10:55:31|
EU expands use of Revlimid to include post ACST use
European regulators have expanded the scope of Celgene's Revlimid to include its use as monotherapy for the maintenance treatment of adults with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation (ASCT).
|PharmaTimes, 2017-02-27 10:50:49|
Merck gears up to file antiviral letermovir in the US, EU
Merck & Co said it is planning to submit regulatory applications for letermovir in the US and European Union sometime this year, on the back of late-stage data showing its promise in preventing a serious viral infection in patients undergoing a bone marrow transplant.
|PharmaTimes, 2017-02-27 10:47:57|
Exonics to use CRISPR in an effort to treat majority of DMD boys
Exonics to use CRISPR in an effort to treat majority of DMD boys badams Mon, 02/27/2017 - 05:43
|Fierce Biotech, 2017-02-27 10:43:33|
Pfizer, Celgene-backed upstart Arrakis hopes to mine RNA spice
Pfizer, Celgene-backed upstart Arrakis hopes to mine RNA spice badams Mon, 02/27/2017 - 05:35
|Fierce Biotech, 2017-02-27 10:35:22|
Study highlights impact of mental health services on young people with psychosis
Smiley hates where she lives. It is 2012 and Smiley, a young woman in her early 20s, lives in a single room occupancy (SRO) building in Vancouver. She wants to hang out with her friends in her room, where she feels safe, but the SRO only allows one visitor at a time.
|News Medical Life Sciences, 2017-02-27 07:33:56|
Universal public coverage of essential medicines could save over $4 billion per year, study finds
Universal public coverage of 117 essential medicines could address the needs of most Canadians for pharmaceutical drugs, and possibly save more than $4 billion a year, according to a new study published http://www.cmaj.ca/site/press/cmaj.161082.pdf in CMAJ.
|News Medical Life Sciences, 2017-02-27 07:24:22|
New guideline urges physicians to help in prevention, treatment of smoking among youth and children
A first-ever guideline from the Canadian Task Force on Preventive Health Care on tobacco use by children and youth aged 5 to 18 years recommends that physicians should play a more active role in the prevention and treatment of cigarette smoking in this age group
|News Medical Life Sciences, 2017-02-27 07:20:33|
GUMC launches phase II clinical study to examine safety of cancer drug for Parkinson's disease
Georgetown University Medical Center today announces the launch of a phase II clinical trial to study the safety of the cancer drug nilotinib and its effects on clinical outcomes and biomarkers in people with Parkinson's disease.
|News Medical Life Sciences, 2017-02-27 06:28:14|